Bulletin
Investor Alert

AmerisourceBergen Corp.

NYS: ABC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 31, 2020, 6:23 p.m.

ABC
/zigman2/quotes/201066379/composite

$

88.50

Change

0.00 0.00%

Volume

Volume 48,416

Quotes are delayed by 20 min

/zigman2/quotes/201066379/composite

Today's close

$ 88.10

$ 88.50

Change

+0.40 +0.45%

Day low

Day high

$87.11

$90.73

Open

52 week low

52 week high

$70.55

$97.50

Open

Company Description

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-nam...

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Valuation

P/E Current

21.82

P/E Ratio (with extraordinary items)

28.15

P/E Ratio (without extraordinary items)

20.39

Price to Sales Ratio

0.10

Price to Book Ratio

5.91

Price to Cash Flow Ratio

7.44

Enterprise Value to EBITDA

7.83

Enterprise Value to Sales

0.10

Total Debt to Enterprise Value

0.24

Efficiency

Revenue/Employee

8,163,142.00

Income Per Employee

38,880.00

Receivables Turnover

15.15

Total Asset Turnover

4.64

Liquidity

Current Ratio

0.95

Quick Ratio

0.54

Cash Ratio

0.11

Profitability

Gross Margin

2.52

Operating Margin

1.04

Pretax Margin

0.54

Net Margin

0.48

Return on Assets

2.21

Return on Equity

29.44

Return on Total Capital

24.56

Return on Invested Capital

11.66

Capital Structure

Total Debt to Total Equity

156.08

Total Debt to Total Capital

60.95

Total Debt to Total Assets

11.39

Long-Term Debt to Equity

151.25

Long-Term Debt to Total Capital

59.06

Officers and Executives

Name Age Officer Since Title
Mr. Steven H. Collis 57 2001 President & Chief Operating Officer
Mr. James Francis Cleary 56 2015 Chief Financial Officer & Executive Vice President
Mr. Dale B. Danilewitz 57 2012 Chief Information Officer & Senior Vice President
Ms. Gina K. Clark 62 2011 Chief Marketing Officer & Executive Vice President
Ms. Leslie E. Donato - 2019 Chief Strategy Officer & Executive Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/23/2020 D. Mark Durcan
Director
1,350   Acquisition at $74.33 per share. 100,345
03/17/2020 John G. Chou
Executive Vice President
2,000   Gift at $86.06 per share. 172,120
03/13/2020 D. Mark Durcan
Director
1,225   Acquisition at $82.62 per share. 101,209
03/09/2020 Steven H. Collis
Chairman, President & CEO; Director
19,905   Disposition at $81.74 per share. 1,627,034
03/09/2020 Steven H. Collis
Chairman, President & CEO; Director
19,905   Derivative/Non-derivative trans. at $68.49 per share. 1,363,293
03/03/2020 D. Mark Durcan
Director
1,360   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2020 Jane Ellen Henney
Director
1,631   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2020 Kathleen W. Hyle
Director
1,360   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2020 Michael J. Long
Director
1,360   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2020 Kathy Habecker Gaddes
Executive Vice President
22,140   Disposition at $96.84 per share. 2,144,037
02/21/2020 Kathy Habecker Gaddes
Executive Vice President
22,140   Derivative/Non-derivative trans. at $75.61 per share. 1,674,005
02/12/2020 Kathleen W. Hyle
Director
2,500   Disposition at $95 per share. 237,500
02/12/2020 Kathleen W. Hyle
Director
2,500   Derivative/Non-derivative trans. at $37.43 per share. 93,575
02/10/2020 Steven H. Collis
Chairman, President & CEO; Director
19,905   Disposition at $93.2 per share. 1,855,146
02/10/2020 Steven H. Collis
Chairman, President & CEO; Director
19,905   Derivative/Non-derivative trans. at $68.49 per share. 1,363,293
02/05/2020 Kathleen W. Hyle
Director
5,000   Disposition at $90 per share. 450,000
02/05/2020 Michael J. Long
Director
27,308   Disposition at $91.18 per share. 2,489,943
02/05/2020 Kathy Habecker Gaddes
Executive Vice President
8,690   Disposition at $91.44 per share. 794,613
02/05/2020 Kathleen W. Hyle
Director
5,000   Derivative/Non-derivative trans. at $37.43 per share. 187,150
02/05/2020 Kathy Habecker Gaddes
Executive Vice President
8,690   Derivative/Non-derivative trans. at $68.49 per share. 595,178
/news/latest/company/us/abc

MarketWatch News on ABC

  1. These 30 S&P 500 stocks actually rose during the disastrous first quarter

    8:43 p.m. Today

    - Philip van Doorn

  2. Mallinckrodt Soars After the Company Agrees to Opioid Settlement

    9:56 a.m. Feb. 25, 2020

    - Barron's Online

  3. AmerisourceBergen stock price target raised to $93 from $79 at Deutsche Bank

    8:23 a.m. Jan. 31, 2020

    - Tomi Kilgore

  4. AmerisourceBergen earnings top estimates

    8:51 a.m. Jan. 30, 2020

    - MarketWatch.com

  5. Oklahoma sues three opioid distributors over ‘man-made crisis’

    8:48 p.m. Jan. 13, 2020

    - Associated Press

  6. Opioid Stocks Fall on News of Federal Criminal Investigation

    11:39 a.m. Nov. 27, 2019

    - Barron's Online

  7. How KKR Could Pull Off a Walgreens Takeover

    1:19 p.m. Nov. 13, 2019

    - Barron's Online

  8. Loading more headlines...
/news/nonmarketwatch/company/us/abc

Other News on ABC

  1. AmerisourceBergen (ABC) Gets a Hold Rating from Morgan Stanley

    9:06 a.m. March 27, 2020

    - SmarterAnalyst

  2. A Director at AmerisourceBergen (ABC) is Buying Shares

    7:18 p.m. March 16, 2020

    - SmarterAnalyst

  3. The Magic Formula Is Back: A Fresh Batch Of 30 Stocks To Watch

    8:19 a.m. March 6, 2020

    - Seeking Alpha

  4. We Could Be Here For A While - Buy Quality

    7:37 a.m. March 6, 2020

    - Seeking Alpha

  5. February 2020 Portfolio Update - Chaos Ensues

    9:40 a.m. March 2, 2020

    - Seeking Alpha

  6. Potholes Remain for Teva Pharmaceutical Stock

    10:02 a.m. Feb. 26, 2020

    - InvestorPlace.com

  7. Mallinckrodt Nets Government Support for $1.6 Billion Opioid Deal

    6:56 p.m. Feb. 25, 2020

    - Alexander Gladstone

  8. Dividend Champion And Contender Highlights: Week Of February 23

    11:39 a.m. Feb. 22, 2020

    - Seeking Alpha

  9. Opioid-related payouts to less than expected - NYT

    7:57 a.m. Feb. 18, 2020

    - Seeking Alpha

  10. Opioid-related payouts to be less than expected - NYT

    7:57 a.m. Feb. 18, 2020

    - Seeking Alpha

  11. Tracking Seth Klarman's Baupost Group Holdings - Q4 2019 Update

    6:27 a.m. Feb. 17, 2020

    - Seeking Alpha

  12. The Best Stocks To Buy Now

    6:46 p.m. Feb. 16, 2020

    - Seeking Alpha

  13. States Spurn Drug Industry’s Opioid-Settlement Offer

    6:58 p.m. Feb. 14, 2020

    - Jared S. Hopkins

  14. 26 Upcoming Dividend Increases Including Chevron

    1:13 p.m. Feb. 7, 2020

    - Seeking Alpha

  15. Baird likes drug wholesalers in premarket analyst action

    7:58 a.m. Feb. 7, 2020

    - Seeking Alpha

  16. A Director at AmerisourceBergen is Exercising Options

    8:52 p.m. Feb. 6, 2020

    - SmarterAnalyst

  17. A Director at AmerisourceBergen is Exercising Options

    7:04 p.m. Feb. 5, 2020

    - SmarterAnalyst

  18. Loading more headlines...

At a Glance

AmerisourceBergen Corp.

1300 Morris Drive

Chesterbrook, Pennsylvania 19087-5594

Phone

1 6107277000

Industry

Drug Retail

Sector

Retail/Wholesale

Fiscal Year-end

09/2020

Revenue

$179.59B

Net Income

$855.37M

2019 Sales Growth

6.9%

Employees

22,000

/news/pressrelease/company/us/abc

Press Releases on ABC

  1. Clinical Trial Market Development Study: Big changes will have a big Impact

    9:00 a.m. March 25, 2020

    - HTF Market Intelligence

  2. Amerisourcebergen $ABC Trading Report

    12:58 p.m. March 16, 2020

    - Stock Traders Daily

  3. Loading more headlines...
Link to MarketWatch's Slice.